Multiple concurrent collagenase clostridium histolyticum injections to Dupuytrens cords: an exploratory study

BMC Musculoskeletal Disorders, 05/04/2012

The results provide preliminary evidence that two cords (affected joints) can be treated concurrently with Collagenase clostridium histolyticum (CCH) with similar efficacy and safety as cords treated individually in a sequential fashion. Multiple concurrent injections would eliminate the 30–day wait between single treatments and allow for rapid and effective treatment of patients with multiple affected joints, a significant advantage for both patient and physician.

Print Article Summary Cat 2 CME Report